ArticleResearch square2023

Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic target.

Marina Ferrari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.